[1] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[2] |
Misra A, Gopalan H, Jayawardena R, et al. Diabetes in develo-ping countries. J Diabetes. 2019,11(7):522-539. doi: 10.1111/1753-0407.12913.
doi: 10.1111/1753-0407.12913
URL
pmid: 30864190
|
[3] |
Lin Y, Harries AD, Kumar AMV, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, World Diabetes Foundation, 2019.
|
[4] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
|
[5] |
陈红光, 刘民, 顾芳慧. 中国大陆地区肺结核合并糖尿病患病率的Meta分析. 中华流行病学杂志, 2013,34(11):1128-1133. doi: 10.3760/cma.j.issn.0254-6450.2013.011.019.
|
[6] |
《中国糖尿病防治指南》编写组. 中国糖尿病防治指南, 北京: 北京大学医学出版社, 2004: 11-12.
|
[7] |
国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020,42(4):301-307. doi: 10.3969/j.issn.1000-6621.2020.04.001.
|
[8] |
Cheng J, Zhang H, Zhao YL, et al. Mutual Impact of Diabetes Mellitus and Tuberculosis in China. Biomed Environ Sci, 2017,30(5):384-389. doi: 10.3967/bes2017.051.
doi: 10.3967/bes2017.051
URL
pmid: 28549496
|
[9] |
Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health, 2010,15(11):1300-1314. doi: 10.1111/j.1365-3156.2010.02632.x.
doi: 10.1111/j.1365-3156.2010.02632.x
URL
pmid: 20958887
|
[10] |
Martinez N, Kornfeld H. Tuberculosis and diabetes: from bench to bedside and back. Int J Tuberc Lung Dis, 2019,23(6):669-677. doi: 10.5588/ijtld.18.0805.
doi: 10.5588/ijtld.18.0805
URL
pmid: 31315698
|
[11] |
Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012,17(10):1302-1308. doi: 10.1111/j.1365-3156.2012.03069.x.
doi: 10.1111/j.1365-3156.2012.03069.x
URL
|
[12] |
汪娟, 许缃, 姜静, 等. 2013—2017年上海市徐汇区糖尿病并发肺结核患者特征登记转归分析. 结核病与肺部健康杂志, 2019,8(1):29-32. doi: 10.3969/j.issn.2095-3755.2019.01.008.
|
[13] |
汪娟, 许缃, 蔡晓峰, 等. 对糖尿病患者进行肺结核筛查的效果与成本效益分析. 中国防痨杂志, 2019,41(9):968-973. doi: 10.3969/j.issn.1000-6621.2019.09.011.
|
[14] |
Ji Y, Cao H, Liu Q, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis, 2020,93:84-89. doi: 10.1016/j.ijid.2020.01.019.
doi: 10.1016/j.ijid.2020.01.019
URL
pmid: 31978585
|
[15] |
Paton NI, Borand L, Benedicto J, et al. Diagnosis and mana-gement of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis, 2019,87:21-29. doi: 10.1016/j.ijid.2019.07.004.
doi: 10.1016/j.ijid.2019.07.004
URL
pmid: 31301458
|
[16] |
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health, 2018,23(10):1058-1070. doi: 10.1111/tmi.13133.
doi: 10.1111/tmi.13133
URL
pmid: 30062731
|
[17] |
Jackson C, Southern J, Lalvani A, et al. Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. Thorax, 2019,74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124.
doi: 10.1136/thoraxjnl-2017-211124
URL
pmid: 29764958
|
[18] |
Lee MR, Huang YP, Kuo YT, et al. Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and Metaanalysis. Clin Infect Dis, 2017,64(6):719-727. doi: 10.1093/cid/ciw836.Erratum in: Clin Infect Dis,2017,65(2):356.
|
[19] |
Oglesby W, Kara AM, Granados H, et al. Metformin in tuberculosis: beyond control of hyperglycemia. Infection, 2019,47(5):697-702. doi: 10.1007/s15010-019-01322-5.
doi: 10.1007/s15010-019-01322-5
URL
pmid: 31119504
|